{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:10:38Z","timestamp":1740107438957,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00280-017-3476-5","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T07:28:09Z","timestamp":1510730889000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3557-0049","authenticated-orcid":false,"given":"Takeshi","family":"Masuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Horimasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintarou","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Ohshimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Fujitaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,15]]},"reference":[{"issue":"Suppl 2","key":"3476_CR1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.bjc.6602061","volume":"91","author":"G Raghu","year":"2004","unstructured":"Raghu G, Nyberg F, Morgan G (2004) The epidemiology of interstitial lung disease and its association with lung cancer. Br J Cancer 91(Suppl 2):S3\u2013S10","journal-title":"Br J Cancer"},{"key":"3476_CR2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","volume":"161","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161:646\u2013664","journal-title":"Am J Respir Crit Care Med"},{"key":"3476_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias","year":"2002","unstructured":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias (2002) This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277\u2013304","journal-title":"Am J Respir Crit Care Med"},{"key":"3476_CR4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ (2011) An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788\u2013824","journal-title":"Am J Respir Crit Care Med"},{"key":"3476_CR5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","volume":"176","author":"HR Collard","year":"2007","unstructured":"Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, Lasky JA, Loyd JE, Noth I, Olman MA, Raghu G, Roman J, Ryu JH, Zisman DA, Hunninghake GW, Colby TV, Egan JJ, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kondoh Y, Lynch DA, Muller-Quernheim J, Myers JL, Nicholson AG, Selman M, Toews GB, Wells AU, Martinez FJ (2007) Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176:636\u2013643","journal-title":"Am J Respir Crit Care Med"},{"key":"3476_CR6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1183\/09031936.06.00114004","volume":"27","author":"DS Kim","year":"2006","unstructured":"Kim DS, Park JH, Park BK, Lee JS, Nicholson AG, Colby T (2006) Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 27:143\u2013150","journal-title":"Eur Respir J"},{"key":"3476_CR7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00005","volume":"142","author":"FJ Martinez","year":"2005","unstructured":"Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, Flaherty KR, Schwartz DA, Noble PW, Raghu G, Brown KK (2005) The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 142:963\u2013967","journal-title":"Ann Intern Med"},{"key":"3476_CR8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2169\/internalmedicine.48.1650","volume":"48","author":"Y Minegishi","year":"2009","unstructured":"Minegishi Y, Takenaka K, Mizutani H, Sudoh J, Noro R, Okano T, Azuma A, Yoshimura A, Ando M, Tsuboi E, Kudoh S, Gemma A (2009) Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy. Intern Med 48:665\u2013672","journal-title":"Intern Med"},{"key":"3476_CR9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1440-1843.2009.01666.x","volume":"15","author":"K Isobe","year":"2010","unstructured":"Isobe K, Hata Y, Sakamoto S, Takai Y, Shibuya K, Homma S (2010) Clinical characteristics of acute respiratory deterioration in pulmonary fibrosis associated with lung cancer following anti-cancer therapy. Respirology 15:88\u201392","journal-title":"Respirology"},{"key":"3476_CR10","first-page":"4357","volume":"30","author":"T Shukuya","year":"2010","unstructured":"Shukuya T, Ishiwata T, Hara M, Muraki K, Shibayama R, Koyama R, Takahashi K (2010) Carboplatin plus weekly paclitaxel treatment in non-small cell lung cancer patients with interstitial lung disease. Anticancer Res 30:4357\u20134361","journal-title":"Anticancer Res"},{"key":"3476_CR11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.lungcan.2010.04.014","volume":"71","author":"Y Minegishi","year":"2011","unstructured":"Minegishi Y, Sudoh J, Kuribayasi H, Mizutani H, Seike M, Azuma A, Yoshimura A, Kudoh S, Gemma A (2011) The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias. Lung Cancer 71:70\u201374","journal-title":"Lung Cancer"},{"key":"3476_CR12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3892\/ol.2012.753","volume":"4","author":"T Kinoshita","year":"2012","unstructured":"Kinoshita T, Azuma K, Sasada T, Okamoto M, Hattori S, Imamura Y, Yamada K, Tajiri M, Yoshida T, Zaizen Y, Kawahara A, Fujimoto K, Hoshino T (2012) Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumonia. Oncol Lett 4:477\u2013482","journal-title":"Oncol Lett"},{"key":"3476_CR13","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00280-014-2458-0","volume":"73","author":"MK Choi","year":"2014","unstructured":"Choi MK, Hong JY, Chang W, Kim M, Kim S, Jung HA, Lee SJ, Park S, Chung MP, Sun JM, Park K, Ahn MJ, Ahn JS (2014) Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease. Cancer Chemother Pharmacol 73:1217\u20131225","journal-title":"Cancer Chemother Pharmacol"},{"key":"3476_CR14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/1471-2407-14-508","volume":"14","author":"M Kato","year":"2014","unstructured":"Kato M, Shukuya T, Takahashi F, Mori K, Suina K, Asao T, Kanemaru R, Honma Y, Muraki K, Sugano K, Shibayama R, Koyama R, Shimada N, Takahashi K (2014) Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease. BMC Cancer 14:508","journal-title":"BMC Cancer"},{"key":"3476_CR15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00280-014-2670-y","volume":"75","author":"H Kenmotsu","year":"2015","unstructured":"Kenmotsu H, Naito T, Mori K, Ko R, Ono A, Wakuda K, Imai H, Taira T, Murakami H, Endo M, Takahashi T (2015) Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease. Cancer Chemother Pharmacol 75:521\u2013526","journal-title":"Cancer Chemother Pharmacol"},{"key":"3476_CR16","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00280-016-3040-8","volume":"77","author":"A Sekine","year":"2016","unstructured":"Sekine A, Satoh H, Baba T, Ikeda S, Okuda R, Shinohara T, Komatsu S, Hagiwara E, Iwasawa T, Ogura T, Kato T (2016) Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study. Cancer Chemother Pharmacol 77:1245\u20131252","journal-title":"Cancer Chemother Pharmacol"},{"key":"3476_CR17","doi-asserted-by":"publisher","unstructured":"Non-Small Cell Lung Cancer Collaborative Group (2010) Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007309.pub2","DOI":"10.1002\/14651858.CD007309.pub2"},{"key":"3476_CR18","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/JTO.0b013e318216ee6b","volume":"6","author":"H Kenmotsu","year":"2011","unstructured":"Kenmotsu H, Naito T, Kimura M, Ono A, Shukuya T, Nakamura Y, Tsuya A, Kaira K, Murakami H, Takahashi T, Endo M, Yamamoto N (2011) The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer. J Thorac Oncol 6:1242\u20131246","journal-title":"J Thorac Oncol"},{"key":"3476_CR19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00280-015-2816-6","volume":"76","author":"Y Enomoto","year":"2015","unstructured":"Enomoto Y, Inui N, Imokawa S, Karayama M, Hasegawa H, Ozawa Y, Matsui T, Yokomura K, Suda T (2015) Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease. Cancer Chemother Pharmacol 76:499\u2013505","journal-title":"Cancer Chemother Pharmacol"},{"key":"3476_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00280-015-2775-y","volume":"76","author":"N Watanabe","year":"2015","unstructured":"Watanabe N, Niho S, Kirita K, Umemura S, Matsumoto S, Yoh K, Ohmatsu H, Goto K (2015) Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia. Cancer Chemother Pharmacol 76:69\u201374","journal-title":"Cancer Chemother Pharmacol"},{"key":"3476_CR21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5301\/tj.5000574","volume":"103","author":"N Asai","year":"2017","unstructured":"Asai N, Katsuda E, Hamanaka R, Kosaka K, Matsubara A, Nishimura M, Tanaka H, Yokoe N, Takahashi A, Yamaguchi E, Kubo A (2017) The ATS\/ERS\/JRS\/ALAT statement \u201cIPF by HRCT\u201d could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer. Tumori 103:60\u201365","journal-title":"Tumori"},{"key":"3476_CR22","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00280-016-3025-7","volume":"77","author":"Y Ozawa","year":"2016","unstructured":"Ozawa Y, Akahori D, Koda K, Abe T, Hasegawa H, Matsui T, Tanahashi M, Niwa H, Yamada K, Yokomura K, Suda T (2016) Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer. Cancer Chemother Pharmacol 77:1031\u20131038","journal-title":"Cancer Chemother Pharmacol"},{"key":"3476_CR23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1164\/rccm.200611-1696OC","volume":"177","author":"H Sumikawa","year":"2008","unstructured":"Sumikawa H, Johkoh T, Colby TV, Ichikado K, Suga M, Taniguchi H, Kondoh Y, Ogura T, Arakawa H, Fujimoto K, Inoue A, Mihara N, Honda O, Tomiyama N, Nakamura H, Muller NL (2008) Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med 177:433\u2013439","journal-title":"Am J Respir Crit Care Med"},{"key":"3476_CR24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1183\/09031936.00106011","volume":"40","author":"M Mura","year":"2012","unstructured":"Mura M, Porretta MA, Bargagli E, Sergiacomi G, Zompatori M, Sverzellati N, Taglieri A, Mezzasalma F, Rottoli P, Saltini C, Rogliani P (2012) Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study. Eur Respir J 40:101\u2013109","journal-title":"Eur Respir J"},{"key":"3476_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","volume":"194","author":"HR Collard","year":"2016","unstructured":"Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, Lee JS, Maher TM, Wells AU, Antoniou KM, Behr J, Brown KK, Cottin V, Flaherty KR, Fukuoka J, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kolb M, Lynch DA, Myers JL, Raghu G, Richeldi L, Taniguchi H, Martinez FJ (2016) Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report. Am J Respir Crit Care Med 194:265\u2013275","journal-title":"Am J Respir Crit Care Med"},{"key":"3476_CR26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1378\/chest.95.4.901","volume":"95","author":"E Zerhouni","year":"1989","unstructured":"Zerhouni E (1989) Computed tomography of the pulmonary parenchyma. An overview. Chest 95:901\u2013907","journal-title":"Chest"},{"key":"3476_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1067\/j.cpradiol.2014.07.005","volume":"44","author":"MA Kadoch","year":"2015","unstructured":"Kadoch MA, Cham MD, Beasley MB, Ward TJ, Jacobi AH, Eber CD, Padilla ML (2015) Idiopathic interstitial pneumonias: a radiology-pathology correlation based on the revised 2013 American Thoracic Society-European Respiratory Society classification system. Curr Probl Diagn Radiol 44:15\u201325","journal-title":"Curr Probl Diagn Radiol"},{"key":"3476_CR28","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/thx.47.12.1064","volume":"47","author":"MN Sheppard","year":"1992","unstructured":"Sheppard MN, Harrison NK (1992) New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis. Thorax 47:1064\u20131074","journal-title":"Thorax"},{"key":"3476_CR29","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00595-010-4384-z","volume":"41","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Sekine Y, Yoshida S, Suzuki M, Shibuya K, Yonemori Y, Hiroshima K, Nakatani Y, Mizuno S, Takiguchi Y, Yoshino I (2011) Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography. Surg Today 41:914\u2013921","journal-title":"Surg Today"},{"key":"3476_CR30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12890-015-0161-5","volume":"15","author":"WM Reichmann","year":"2015","unstructured":"Reichmann WM, Yu YF, Macaulay D, Wu EQ, Nathan SD (2015) Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis. BMC Pulm Med 15:167","journal-title":"BMC Pulm Med"},{"key":"3476_CR31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.resinv.2012.02.001","volume":"50","author":"N Ishikawa","year":"2012","unstructured":"Ishikawa N, Hattori N, Yokoyama A, Kohno N (2012) Utility of KL-6\/MUC1 in the clinical management of interstitial lung diseases. Respir Investig 50:3\u201313","journal-title":"Respir Investig"},{"key":"3476_CR32","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.rmed.2014.04.009","volume":"108","author":"S Ohshimo","year":"2014","unstructured":"Ohshimo S, Ishikawa N, Horimasu Y, Hattori N, Hirohashi N, Tanigawa K, Kohno N, Bonella F, Guzman J, Costabel U (2014) Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis. Respir Med 108:1031\u20131039","journal-title":"Respir Med"},{"key":"3476_CR33","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/ijc.22613","volume":"120","author":"J Inata","year":"2007","unstructured":"Inata J, Hattori N, Yokoyama A, Ohshimo S, Doi M, Ishikawa N, Hamada H, Kohno N (2007) Circulating KL-6\/MUC1 mucin carrying sialyl Lewisa oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma. Int J Cancer 120:2643\u20132649","journal-title":"Int J Cancer"},{"key":"3476_CR34","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/ijc.23411","volume":"122","author":"N Ishikawa","year":"2008","unstructured":"Ishikawa N, Hattori N, Yokoyama A, Tanaka S, Nishino R, Yoshioka K, Ohshimo S, Fujitaka K, Ohnishi H, Hamada H, Arihiro K, Kohno N (2008) Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors. Int J Cancer 122:2612\u20132620","journal-title":"Int J Cancer"},{"key":"3476_CR35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.lungcan.2016.03.017","volume":"96","author":"Y Enomoto","year":"2016","unstructured":"Enomoto Y, Inui N, Kato T, Baba T, Karayama M, Nakamura Y, Ogura T, Suda T (2016) Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer. Lung Cancer 96:63\u201367","journal-title":"Lung Cancer"},{"key":"3476_CR36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/09031936.00159709","volume":"37","author":"JW Song","year":"2011","unstructured":"Song JW, Hong SB, Lim CM, Koh Y, Kim DS (2011) Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 37:356\u2013363","journal-title":"Eur Respir J"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-017-3476-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3476-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3476-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T01:18:23Z","timestamp":1570324703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-017-3476-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,15]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["3476"],"URL":"https:\/\/doi.org\/10.1007\/s00280-017-3476-5","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2017,11,15]]}}}